Javascript must be enabled to continue!
Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours: Predicting clinical risk factors for thrombolytic therapy
View through CrossRef
Abstract
Background Acute ischemic stroke attack with and without a recent TIA within or less than 24 hours may differ in clinical risk factors, and this may affect treatment outcomes following thrombolytic therapy. We examined whether the odds of exclusion or inclusion for thrombolytic therapy are greater in ischemic stroke with TIA less than 24 hours preceding ischemic stroke(TIA-24hr-ischemic stroke patients) as compared to those without recent TIA or non-TIA <24 hours.Methods A retrospective hospital-based analysis was conducted on 6,315 ischemic stroke patients, of whom 846 had proven brain diffusion-weighted magnetic resonance imaging (DW-MRI) of an antecedent TIA within 24 hours prior to ischemic stroke. The logistic regression model was developed to generate odds ratios (OR) to determine clinical factors that may increase the likelihood of exclusion or inclusion for thrombolytic therapy. The validity of the model was tested using a Hosmer-Lemeshow test, while the Receiver Operating Curve (ROC) was used to test the sensitivity of our model.Results In TIA-24hr-ischemic stroke population, patients with a history of alcohol abuse (OR = 5.525, 95% CI, 1.003-30.434, p = 0.05), migraine (OR=4.277, 95% CI, 1.095-16.703, p=0.037), and increasing NIHSS score (OR=1.156, 95% CI, 1.058-1.263, p = 0.001) were associated with the increasing odds of receiving rtPA, while older patients (OR = 0.965, 95% CI, 0.934‐0.997, P = 0.033) were associated with the increasing odds of not receiving rtPA.Conclusion In TIA-24hr-ischemic stroke patients, older patients with higher INR values are associated with increasing odds of exclusion from thrombolytic therapy. Our findings demonstrate clinical risks factors that can be targeted to improve the use and eligibility for rtPA in in TIA-24hr-ischemic stroke patients.
Springer Science and Business Media LLC
Title: Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours: Predicting clinical risk factors for thrombolytic therapy
Description:
Abstract
Background Acute ischemic stroke attack with and without a recent TIA within or less than 24 hours may differ in clinical risk factors, and this may affect treatment outcomes following thrombolytic therapy.
We examined whether the odds of exclusion or inclusion for thrombolytic therapy are greater in ischemic stroke with TIA less than 24 hours preceding ischemic stroke(TIA-24hr-ischemic stroke patients) as compared to those without recent TIA or non-TIA <24 hours.
Methods A retrospective hospital-based analysis was conducted on 6,315 ischemic stroke patients, of whom 846 had proven brain diffusion-weighted magnetic resonance imaging (DW-MRI) of an antecedent TIA within 24 hours prior to ischemic stroke.
The logistic regression model was developed to generate odds ratios (OR) to determine clinical factors that may increase the likelihood of exclusion or inclusion for thrombolytic therapy.
The validity of the model was tested using a Hosmer-Lemeshow test, while the Receiver Operating Curve (ROC) was used to test the sensitivity of our model.
Results In TIA-24hr-ischemic stroke population, patients with a history of alcohol abuse (OR = 5.
525, 95% CI, 1.
003-30.
434, p = 0.
05), migraine (OR=4.
277, 95% CI, 1.
095-16.
703, p=0.
037), and increasing NIHSS score (OR=1.
156, 95% CI, 1.
058-1.
263, p = 0.
001) were associated with the increasing odds of receiving rtPA, while older patients (OR = 0.
965, 95% CI, 0.
934‐0.
997, P = 0.
033) were associated with the increasing odds of not receiving rtPA.
Conclusion In TIA-24hr-ischemic stroke patients, older patients with higher INR values are associated with increasing odds of exclusion from thrombolytic therapy.
Our findings demonstrate clinical risks factors that can be targeted to improve the use and eligibility for rtPA in in TIA-24hr-ischemic stroke patients.
Related Results
Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours and thrombolytic therapy
Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours and thrombolytic therapy
Abstract
Background Acute ischemic stroke attack with and without a recent TIA within or less than 24 hours may differ in clinical risk factors, and this may affect treatme...
Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours and thrombolytic therapy
Ischemic stroke with a preceding Trans ischemic attack(TIA) less than 24 hours and thrombolytic therapy
Abstract
Background Acute ischemic stroke attack with and without a recent TIA within or less than 24 hours may differ in clinical risk factors, and this may affect treatme...
Dementia Risk Following Ischemic Stroke: A Systematic Review and Meta-Analysis of Factors Collected at Time of Stroke Diagnosis
Dementia Risk Following Ischemic Stroke: A Systematic Review and Meta-Analysis of Factors Collected at Time of Stroke Diagnosis
Abstract
Objective
To assess incidence rates and predictors of dementia after ischemic stroke.
...
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
1177 SOCIO-DEMOGRAPHIC AND RISK FACTOR DIFFERENCES BETWEEN TIA AND TIA MIMICS
1177 SOCIO-DEMOGRAPHIC AND RISK FACTOR DIFFERENCES BETWEEN TIA AND TIA MIMICS
Abstract
Introduction
Diagnosis of Transient Ischaemic Attack [TIA] is important to minimise risk of future strokes. This retros...
A STUDY TO ANALYSE THE ROLE OF HbA1C IN THE RISK PREDICTIONOF ISCHEMIC STROKE AND TRANSIENT ISCHEMIC ATTACKS
A STUDY TO ANALYSE THE ROLE OF HbA1C IN THE RISK PREDICTIONOF ISCHEMIC STROKE AND TRANSIENT ISCHEMIC ATTACKS
Background: Stroke is the second most important cause of mortality worldwide. Diabetes mellitus is a major risk factor for the development of stroke, particularly ischemic stroke. ...
CASE SERIES: EFFICACY OF THROMBOLYSIS USING INTRAVENOUS ALTEPLASE IN ACUTE ISCHEMIC STROKE WITH ONSET LESS THAN 6 HOURS (CODE STROKE)
CASE SERIES: EFFICACY OF THROMBOLYSIS USING INTRAVENOUS ALTEPLASE IN ACUTE ISCHEMIC STROKE WITH ONSET LESS THAN 6 HOURS (CODE STROKE)
Background: The gold standard therapy for acute ischemic stroke is timely reperfusion of ischemic brain tissue. Intravenous thrombolysis with tPA is the only proven medical therapy...
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
Hypertension, Age, Sex, and Stroke Incidence In Stroke Installation Room RSUD dr. M. Yunus BengkuluABSTRAKStroke adalah gejala-gejala defisit fungsi susunan saraf yang diakibatka...

